Marta Bogowicz1, Oliver Riesterer2, Kristian Ikenberg3, Sonja Stieb2, Holger Moch3, Gabriela Studer2, Matthias Guckenberger2, Stephanie Tanadini-Lang2. 1. Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland. Electronic address: marta.nesteruk@usz.ch. 2. Department of Radiation Oncology, University Hospital Zurich and University of Zurich, Zurich, Switzerland. 3. Department of Pathology and Molecular Pathology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.
Abstract
PURPOSE: This study aimed to predict local tumor control (LC) after radiochemotherapy of head and neck squamous cell carcinoma (HNSCC) and human papillomavirus (HPV) status using computed tomography (CT) radiomics. METHODS AND MATERIALS: HNSCC patients treated with definitive radiochemotherapy were included in the retrospective study approved by the local ethical commission (93 and 56 patients in the training and validation cohorts, respectively). Three hundred seventeen CT radiomic features, including those based on shape, intensity, texture, and wavelet transform, were calculated in the primary tumor region. Cox and logistic regression models were built to predict LC and HPV status, respectively. The best-performing features in the univariable analysis were included in the multivariable analysis after the exclusion of redundant features. The quality of the models was assessed using the concordance index (CI) for modeling of LC and receiver operating characteristics area under the curve (AUC) for HPV status prediction. The radiomics LC model was compared to a model incorporating clinical parameters (tumor stage, volume, and HPV status) and a mixed model. RESULTS: A radiomic signature comprising 3 features was significantly associated with LC (CItraining = 0.75 and CIvalidation = 0.78), showing that tumors with a more heterogeneous CT density distribution are at risk for decreased LC. The addition of clinical parameters to the radiomics model slightly improved the model in the training cohort but not in the validation cohort. Another radiomic signature showed good performance in HPV status prediction (AUCtraining = 0.85 and AUCvalidation = 0.78) and indicated that HPV-positive tumors have a more homogenous CT density distribution. CONCLUSIONS: Heterogeneity of HNSCC tumor density, quantified by CT radiomics, is associated with LC after radiochemotherapy and HPV status.
PURPOSE: This study aimed to predict local tumor control (LC) after radiochemotherapy of head and neck squamous cell carcinoma (HNSCC) and human papillomavirus (HPV) status using computed tomography (CT) radiomics. METHODS AND MATERIALS: HNSCCpatients treated with definitive radiochemotherapy were included in the retrospective study approved by the local ethical commission (93 and 56 patients in the training and validation cohorts, respectively). Three hundred seventeen CT radiomic features, including those based on shape, intensity, texture, and wavelet transform, were calculated in the primary tumor region. Cox and logistic regression models were built to predict LC and HPV status, respectively. The best-performing features in the univariable analysis were included in the multivariable analysis after the exclusion of redundant features. The quality of the models was assessed using the concordance index (CI) for modeling of LC and receiver operating characteristics area under the curve (AUC) for HPV status prediction. The radiomics LC model was compared to a model incorporating clinical parameters (tumor stage, volume, and HPV status) and a mixed model. RESULTS: A radiomic signature comprising 3 features was significantly associated with LC (CItraining = 0.75 and CIvalidation = 0.78), showing that tumors with a more heterogeneous CT density distribution are at risk for decreased LC. The addition of clinical parameters to the radiomics model slightly improved the model in the training cohort but not in the validation cohort. Another radiomic signature showed good performance in HPV status prediction (AUCtraining = 0.85 and AUCvalidation = 0.78) and indicated that HPV-positive tumors have a more homogenous CT density distribution. CONCLUSIONS: Heterogeneity of HNSCC tumor density, quantified by CT radiomics, is associated with LC after radiochemotherapy and HPV status.
Authors: Rachel B Ger; Daniel F Craft; Dennis S Mackin; Shouhao Zhou; Rick R Layman; A Kyle Jones; Hesham Elhalawani; Clifton D Fuller; Rebecca M Howell; Heng Li; R Jason Stafford; Laurence E Court Journal: Comput Med Imaging Graph Date: 2018-09-15 Impact factor: 4.790
Authors: Yitan Zhu; Abdallah S R Mohamed; Stephen Y Lai; Shengjie Yang; Aasheesh Kanwar; Lin Wei; Mona Kamal; Subhajit Sengupta; Hesham Elhalawani; Heath Skinner; Dennis S Mackin; Jay Shiao; Jay Messer; Andrew Wong; Yao Ding; Lifei Zhang; Laurence Court; Yuan Ji; Clifton D Fuller Journal: JCO Clin Cancer Inform Date: 2019-02
Authors: Yura Ahn; Young Jun Choi; Yu Sub Sung; Josef Pfeuffer; Chong Hyun Suh; Sae Rom Chung; Jung Hwan Baek; Jeong Hyun Lee Journal: Neuroradiology Date: 2021-06-29 Impact factor: 2.804
Authors: Tamari A Miller; Kayla R Robinson; Hui Li; Tanguy Y Seiwert; Daniel J Haraf; Li Lan; Maryellen L Giger; Daniel T Ginat Journal: Quant Imaging Med Surg Date: 2019-03